跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
专注达 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Methylphenidate Hydrochloride Prolonged-Release Tablets
Approved
化学药品
Methylphenidate Hydrochloride Prolonged-Release Tablets
JANSSEN PHARMACEUTICALS, INC.
🇨🇳 National Medical Products Administration
Approval Date
Jun 9, 2022
Approval ID
8H1Or9FPmWB
Company
JANSSEN PHARMACEUTICALS, INC.
Type
化学药品
Approval Details
Approval Id
8H1Or9FPmWB
Approval Number
国药准字HJ20170265
Generic Name
盐酸哌甲酯缓释片
Generic Name En
Methylphenidate Hydrochloride Prolonged-Release Tablets
Trade Name
专注达
Drug Type
化学药品
Dosage Form
片剂
Strength
36mg
Reg Date
2022-06-09
Expired Date
2027-06-08
Company Name
JANSSEN PHARMACEUTICALS, INC.
Production Company Name
Janssen-Cilag Manufacturing, LLC
Company Detail Path
/organization/janssen-pharmaceuticals-inc
Production Company Detail Path
/organization/janssen-cilag-manufacturing-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 9, 2022
Approval ID
8H1Or9FPmWB
Type
化学药品
Back to NMPA Approvals